Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin in Traumatic Brain Injury
NCT00987454Phase 3Completed
- Sponsor
- Australian and New Zealand Intensive Care Research Centre
- Start
- May 2010
- Primary completion
- May 2015
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 7
01
Overview
A Phase 3 trial of epoetin alfa in traumatic brain injury (TBI), sponsored by Australian and New Zealand Intensive Care Research Centre. Started May 2010; status: completed.
02
Drugs
epoetin alfa
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT00987454.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00987454.